Background and objectives: Composite measures are increasingly used to assess quality of care in surgical oncology. We sought to define the incidence of “textbook oncologic outcome” (TOO) following resection of gastric adenocarcinoma among a large, international cohort of patients. Methods: Gastric adenocarcinoma patients undergoing resection between 2000 and 2020 were identified from an international database. TOO was defined as margin-negative resection, examination of ≥16 lymph nodes, no prolonged length-of-stay (LOS), no 30-day mortality, and stage-appropriate receipt of chemotherapy. Results: Among a total of 910 patients, 321 patients (35.3%) achieved a postoperative TOO. While failure to evaluate ≥16 lymph nodes (n = 591, 65.0%) and receipt of chemotherapy (n = 651, 71.5%) had the greatest negative impact on the ability to obtain a TOO, no 30-day mortality (n = 880, 96.7%), margin-negative resection (n = 831, 91.3%), and no extended LOS (n = 706, 77.6%) were more commonly achieved. No postoperative complications (OR: 0.44; 95% CI: 0.31−0.63) and T1a/T1b-stage disease (OR: 2.87; 95% CI: 1.59−5.18) were independently associated with achieving a TOO (p < 0.05). The odds of achieving a TOO improved over time (p-trend < 0.05), which was largely attributable to improved odds of evaluating ≥16 lymph nodes (2010−2014 vs. 2000−2004: OR, 5.21; 95% CI: 3.22−8.45). Conclusions: Only about one in three patients achieved a TOO following resection of gastric adenocarcinoma. Odds of TOO increased over time, largely due to improved lymph node evaluation.
Titolo: | Surgical treatment of gastric adenocarcinoma: Are we achieving textbook oncologic outcomes for our patients? | |
Autori: | ||
Data di pubblicazione: | 2021 | |
Rivista: | ||
Abstract: | Background and objectives: Composite measures are increasingly used to assess quality of care in surgical oncology. We sought to define the incidence of “textbook oncologic outcome” (TOO) following resection of gastric adenocarcinoma among a large, international cohort of patients. Methods: Gastric adenocarcinoma patients undergoing resection between 2000 and 2020 were identified from an international database. TOO was defined as margin-negative resection, examination of ≥16 lymph nodes, no prolonged length-of-stay (LOS), no 30-day mortality, and stage-appropriate receipt of chemotherapy. Results: Among a total of 910 patients, 321 patients (35.3%) achieved a postoperative TOO. While failure to evaluate ≥16 lymph nodes (n = 591, 65.0%) and receipt of chemotherapy (n = 651, 71.5%) had the greatest negative impact on the ability to obtain a TOO, no 30-day mortality (n = 880, 96.7%), margin-negative resection (n = 831, 91.3%), and no extended LOS (n = 706, 77.6%) were more commonly achieved. No postoperative complications (OR: 0.44; 95% CI: 0.31−0.63) and T1a/T1b-stage disease (OR: 2.87; 95% CI: 1.59−5.18) were independently associated with achieving a TOO (p < 0.05). The odds of achieving a TOO improved over time (p-trend < 0.05), which was largely attributable to improved odds of evaluating ≥16 lymph nodes (2010−2014 vs. 2000−2004: OR, 5.21; 95% CI: 3.22−8.45). Conclusions: Only about one in three patients achieved a TOO following resection of gastric adenocarcinoma. Odds of TOO increased over time, largely due to improved lymph node evaluation. | |
Handle: | http://hdl.handle.net/11577/3411210 | |
Appare nelle tipologie: | 01.01 - Articolo in rivista |